Skip to main content

Table 1 Baseline characteristics of symptomatic adult patients hospitalized with COVID-19

From: Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry

 

History of Cancer

Characteristic

No (N = 7330)

Yes (N = 892)

p value

Age (years)

60.4 (17.4)

70.6 (14.1)

 < 0.001

Female Sex

3231 (44.1)

421 (47.2)

0.077

BMI (kg/m2)

30.6 (8.2)

28.5 (7.7)

 < 0.001

Race

 White

4522 (61.7)

598 (67.0)

0.009

 Black

1736 (23.7)

194 (21.8)

 Asian/Pacific Islander

469 (6.4)

46 (5.2)

 Other

603 (8.2)

54 (6.1)

Payment Source

 Uninsured

521 (7.1)

22 (2.5)

 < 0.001

 Private

3946 (54.0)

459 (51.6)

 Medicare

1267 (17.4)

274 (30.7)

 Medicaid

1310 (17.9)

124 (13.9)

 Other

259 (3.6)

11 (1.2)

 Atrial Fibrillation/Flutter

626 (8.5)

131 (14.7)

 < 0.001

 Diabetes Mellitus

2722 (37.1)

328 (36.8)

0.832

 Pulmonary Disease

2522 (34.4)

380 (42.6)

 < 0.001

 Chronic Kidney Disease

928 (12.7)

146 (16.4)

0.002

 Hypertension

4287 (58.5)

616 (69.1)

 < 0.001

 Smoking History

461 (6.3)

61 (6.8)

0.53

 Pulmonary Disease

1305 (17.8)

203 (22.8)

 < 0.001

Admission Symptoms

 Fever/Chills

4823 (65.8)

550 (61.7)

0.014

 Cough

4867 (66.4)

534 (59.9)

 < 0.001

 Shortness of Breath

4552 (62.1)

513 (57.5)

0.008

 Fatigue

1845 (25.2)

232 (26.0)

0.59

 Headache

722 (9.9)

49 (5.49)

 < 0.001

 Myalgia

1580 (21.6)

188 (21.1)

0.74

 Sore Throat

506 (6.9)

53 (5.94)

0.28

 Nasal Congestion

375 (5.1)

53 (5.94)

0.30

 Nausea/Vomiting/ Diarrhea

2066 (28.2)

254 (28.5)

0.86

 Loss of Smell/Taste

303 (4.1)

44 (4.9)

0.26

 Confusion or AMS

770 (10.5)

145 (16.3)

 < 0.001

COVID-19 Therapies

 Corticosteroid

1547 (21.8)

203 (24.7)

0.056

 Immunoglobulin

53 (0.7)

12 (1.4)

0.05

 Convalescent serum

195 (2.7)

27 (3.1)

0.54

 Ritonavir/Lopinavir

76 (1.1)

7 (0.9)

0.60

 Remdesivir

565 (7.8)

105 (11.9)

 < 0.001

 Tocilizumab

523 (7.2)

62 (7.0)

0.82

 Chemotherapy/biologics

14 (0.19)

124 (14.0)

 < 0.001

 History of CVD

1544 (21.1)

261 (29.3)

 < 0.001

  1. Values are depicted as mean (standard deviation) or percentage (N) when appropriate
  2. BMI Body Mass Index, AMS Altered Mental Status, CVD Cardiovascular Disease